W. Amick
Directeur/Bestuurslid bij BioRexis Pharmaceutical Corp.
Profiel
W.
Thomas Amick currently works at BioRexis Pharmaceutical Corp., as Director.
Mr. Amick also formerly worked at Windtree Therapeutics, Inc., as Chairman & Chief Executive Officer from 2010 to 2013, Dendreon Corp., as President, Chief Executive Officer & Director from 2014 to 2015, Aldagen, Inc., as President & Chief Executive Officer in 2010, Argolyn Bioscience, Inc., as Chairman in 2009, Biolex Therapeutics, Inc., as Director, Transport Pharmaceuticals, Inc., as Director, Janssen-Cilag International NV, as President-Ortho Biotech Europe in 2003, Johnson & Johnson Innovation - JJDC, Inc., as Vice President-Business Development from 1974 to 2004, Pappas Capital LLC, as Venture Partner, Ortho Biotech Products LP, as President-Europe in 2003, and Janssen, Inc., as President in 2000.
Mr. Amick received his undergraduate degree from Elon University.
Actieve functies van W. Amick
| Bedrijven | Functie | Begin |
|---|---|---|
BioRexis Pharmaceutical Corp.
 BioRexis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology BioRexis Pharmaceutical Corp. provides novel protein and peptide drugs with pharmacology and trans-bodies to replace conventional monoclonal antibodies. The company was founded by Christopher P. Prior, Andrew Turner and David R. King in 2002 and is headquartered in Rosemont, PA. | Directeur/Bestuurslid | - |
Eerdere bekende functies van W. Amick
| Bedrijven | Functie | Einde |
|---|---|---|
| DENDREON CORPORATION | Algemeen Directeur | 27-02-2015 |
| WINDTREE THERAPEUTICS, INC. | Voorzitter | 04-01-2013 |
Aldagen, Inc.
 Aldagen, Inc. Pharmaceuticals: GenericHealth Technology Aldagen, Inc. develops and produces pharmaceutical products. It focuses on developing product candidates to address cardiovascular disease. The firm develops ALD-301 for the treatment of critical limb ischemia; ALD-201 for the treatment of ischemic heart failure; and ALD-401 for the post-acute treatment of ischemic stroke. The company also supplies ALDHbr cells for use in investigator-sponsored clinical studies. Aldagen was founded by Andrew E. Balber, Michael Sherman Colvin, Clay Smith and Nelson Chao in March 2000 and is headquartered in Durham, NC. | Voorzitter | 24-02-2010 |
Argolyn Bioscience, Inc.
 Argolyn Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Argolyn Bioscience, Inc. discovers and develops therapeutic products. It uses amino acid analog substitution technology to enable discovery of novel drug candidates. The firm's products pipeline include library construction, lead identification, and preclinical & clinical development. The company was founded by Thomas A. Dix in May 2002 and is headquartered in Durham, NC. | Voorzitter | 26-11-2009 |
Pappas Capital LLC
 Pappas Capital LLC Investment ManagersFinance Pappas Capital LLC (Pappas Ventures) is a venture capital firm founded in 1994 by Art M. Pappas. The firm is headquartered in Durham, North Carolina. | Corporate Officer/Principal | 31-12-2007 |
Opleiding van W. Amick
| Elon University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| WINDTREE THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 11 |
|---|---|
Transport Pharmaceuticals, Inc.
 Transport Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Transport Pharmaceuticals, Inc. engaged in the development of medical products for the treatment of multiple dermatological diseases. It developed iontophoretic technique to effect trans-dermal drug delivery for a number of dermatological conditions. The company was founded by Dennis I. Goldberg in 1999 and was headquartered in Framingham, MA. | Health Technology |
Biolex Therapeutics, Inc.
 Biolex Therapeutics, Inc. Medical DistributorsDistribution Services Biolex Therapeutics, Inc. developed and produced drugs. The company was founded in 1997 and was headquartered in Pittsboro, NC. | Distribution Services |
BioRexis Pharmaceutical Corp.
BioRexis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology BioRexis Pharmaceutical Corp. provides novel protein and peptide drugs with pharmacology and trans-bodies to replace conventional monoclonal antibodies. The company was founded by Christopher P. Prior, Andrew Turner and David R. King in 2002 and is headquartered in Rosemont, PA. | Health Technology |
Argolyn Bioscience, Inc.
Argolyn Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Argolyn Bioscience, Inc. discovers and develops therapeutic products. It uses amino acid analog substitution technology to enable discovery of novel drug candidates. The firm's products pipeline include library construction, lead identification, and preclinical & clinical development. The company was founded by Thomas A. Dix in May 2002 and is headquartered in Durham, NC. | Health Technology |
Pappas Capital LLC
Pappas Capital LLC Investment ManagersFinance Pappas Capital LLC (Pappas Ventures) is a venture capital firm founded in 1994 by Art M. Pappas. The firm is headquartered in Durham, North Carolina. | Finance |
Aldagen, Inc.
Aldagen, Inc. Pharmaceuticals: GenericHealth Technology Aldagen, Inc. develops and produces pharmaceutical products. It focuses on developing product candidates to address cardiovascular disease. The firm develops ALD-301 for the treatment of critical limb ischemia; ALD-201 for the treatment of ischemic heart failure; and ALD-401 for the post-acute treatment of ischemic stroke. The company also supplies ALDHbr cells for use in investigator-sponsored clinical studies. Aldagen was founded by Andrew E. Balber, Michael Sherman Colvin, Clay Smith and Nelson Chao in March 2000 and is headquartered in Durham, NC. | Health Technology |
Johnson & Johnson Innovation - JJDC, Inc.
 Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey. | Finance |
Janssen-Cilag International NV
 Janssen-Cilag International NV BiotechnologyHealth Technology Part of Johnson & Johnson, Janssen-Cilag International NV is a Belgian company that develops novel medicines and solutions. Bart Willem van Zijll Langhout has been the CEO of the company since 2009. | Health Technology |
Janssen, Inc.
 Janssen, Inc. Pharmaceuticals: MajorHealth Technology Janssen, Inc. operates as a pharmaceutical company of Johnson & Johnson. Its products include Caelyx, Concerta, Cyclen, Ditropan XL, Duragesic, Edurant, Evra, Galexos, Invega, Invokana, Jurnista, Livostin, Pariet, Remicade, Sylvant, Topamax, Ultram, Velcade, Yondelis, and Zytiga. The company is headquartered in Toronto, Canada. | Health Technology |
Ortho Biotech Products LP
 Ortho Biotech Products LP Pharmaceuticals: MajorHealth Technology Ortho Biotech Products LP provides innovative products and services which are designed to enhance the lives of individuals with serious chronic illnesses. The company's products include PROCRIT, DOXIL and LEUSTATIN. Ortho Biotech Products was founded in 1990 and is headquartered in Bridgewater, NJ | Health Technology |
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
